Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.
about
Serodiagnosis as adjunct assay for pertussis infection in São Paulo, Brazil.Pertussis serodiagnosis in Belgium from 1990 to 2009.Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques.Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.Prospective evaluation of an Australian pertussis toxin IgG and IgA enzyme immunoassay.Does tetanus-diphtheria-acellular pertussis vaccination interfere with serodiagnosis of pertussis infection?Laboratory Diagnosis of Pertussis.Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.Evaluation of Commercial Assays for Single-Point Diagnosis of Pertussis in the US.Expanding Pertussis Epidemiology in 6 Latin America Countries through the Latin American Pertussis Project.Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT).Pertussis and the Minnesota State Fair: Demonstrating a Novel Setting for Efficiently Conducting Seroepidemiologic Studies.Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011.
P2860
Q33601914-84FC97D8-3E3F-470F-8139-67831BDCA088Q35066316-589348EE-273A-4DC1-9C41-6997EE321FE0Q35648017-DDC1BC48-7A10-4F0A-9984-7619161CBE73Q35666201-731AC561-27A4-4DEB-ADC7-5D11ECD7CFF6Q35739076-EF18C67F-B510-4E83-A990-51FD86A9A3B5Q36017781-784F07E7-827E-4858-8F9A-200677A14AABQ36073693-172E834D-7001-4B65-9D7F-BBB3120E3A0BQ41428707-8D1CDA42-F102-4829-9EFE-30D15C87C849Q46488763-AB18AB97-28B3-458D-A8EC-799551EBBDEDQ47102144-B3EDF8A9-D594-473D-AB4B-A7468EA813A9Q52589859-6B32DF46-ED07-4CAE-A699-83C3C573BBA4Q52600331-F1D5BCBF-EA9E-4EC7-8B06-49B07F41D35DQ54286582-0FD52A86-76C8-4918-B414-DBC6FEDF5ECA
P2860
Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development and analytical val ...... ordetella pertussis infection.
@en
Development and analytical val ...... ordetella pertussis infection.
@nl
type
label
Development and analytical val ...... ordetella pertussis infection.
@en
Development and analytical val ...... ordetella pertussis infection.
@nl
prefLabel
Development and analytical val ...... ordetella pertussis infection.
@en
Development and analytical val ...... ordetella pertussis infection.
@nl
P2093
P2860
P356
P1476
Development and analytical val ...... ordetella pertussis infection.
@en
P2093
Andrew L Baughman
Bruce D Meade
Lucia C Pawloski
Maria Lucia C Tondella
Monte Martin
Pertussis Assay Working Group
Sandra L Menzies
Tsai-Lien Lin
Vijay Kadwad
P2860
P304
P356
10.1128/CVI.00248-09
P577
2009-10-28T00:00:00Z